Advertisement
Research Article
Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model
Cristina Martínez-García, Adriana Izquierdo, Vidya Velagapudi, Yurena Vivas, Ismael Velasco, Mark Campbell, Keith Burling, Fernando Cava, Manuel Ros, Matej Orešič, Antonio Vidal-Puig, Gema Medina-Gomez
Disease Models & Mechanisms 2012 5: 636-648; doi: 10.1242/dmm.009266

Article Figures & Tables

Figures

  • Table 1.
  • Fig. 1.
    Fig. 1.

    Incipient kidney renal injury in POKO mice at 4 weeks of age. (A) Representative immunoblot for p27Kip1 of renal protein from 4-week-old male WT, PPARγ2 KO, ob/ob and POKO mice. Levels were normalized to β-actin. Each value is the optical intensity of each band as a fold induction vs the WT control group (n=6). Fold induction is shown in graphic. *P<0.05 POKO vs ob/ob. (B) Total kidney mRNA levels of different genes from 4-week-old-male mice of each group. Data are means±s.e.m.; n=8–9 in each group; **P<0.01, ***P<0.001 POKO vs ob/ob; #P<0.05 POKO vs WT; $P<0.05 ob/ob vs WT. Normalized levels with BestKeeper (Bk).

  • Fig. 2.
    Fig. 2.

    Ultrastructural changes in the glomeruli of the POKO mice. (A) Transmission electron microscopy of glomeruli of 4-week-old POKO mice with broadening of foot processes (arrows). Foot processes in POKO mice are completely lost by 12 weeks (arrows). Original magnification: 20,000×. (B) GBM thickening in POKO mice when measuring the lamina densa (n=3–4). GBM thicknesses (white star in A) were measured across the whole GBM and across the lamina densa. Data are means±s.e.m.; n=6 in each group; ***P<0.001 POKO vs ob/ob; #P<0.05, ###P<0.001 POKO vs WT; $$P<0.01, $$$P<0.001 ob/ob vs WT.

  • Fig. 3.
    Fig. 3.

    Insulin resistance in POKO kidneys. (A) Total kidney mRNA levels of glucose metabolism genes from 4-week-old male WT, PPARγ2 KO, ob/ob and POKO mice. Data are means±s.e.m.; n=8–9. *P<0.05 POKO vs ob/ob; #P<0.05 POKO vs WT; $P<0.05 ob/ob vs WT; ϕP<0.05 PPARγ2 KO vs WT. Normalized levels with BestKeeper (Bk). (B) Representative immunoblot for pAKT(Ser473) from WT, ob/ob and POKO 4-week-old-male mice treated and non treated with insulin. Levels were normalized to total protein kinase B (AKTt). Each value is the relative optical intensity of each band normalized as a percentage of the saline-treated group. Values are represented in graphic (n=5–8). Data are means±s.e.m. *P<0.05 WT saline vs WT insulin. G6Pase, glucose 6-phosphatase; PEPCK, phosphoenolpyruvate carboxykinase; IRS, insulin receptor substrate.

  • Fig. 4.
    Fig. 4.

    Altered lipid metabolism in POKO kidneys. (A) Representative Oil-Red-O staining in the kidney from WT, PPARγ2 KO, ob/ob and POKO mice at 4 weeks. Original magnification: 400× (n=4). (B) Intraglomerular electron micrographs of ob/ob mice (12,000×) and POKO mice (15,000×) showing accumulation of lipid droplets (arrows). (C) Total kidney mRNA levels of lipid metabolism genes from 4-week-old male WT, PPARγ2 KO, ob/ob and POKO mice. Data are means±s.e.m.; n=8–9. *P<0.05, **P<0.01, ***P<0.001 POKO vs ob/ob; #P<0.05 POKO vs WT; ϕP<0.05 PPARγ2 KO vs WT. Normalized levels with BestKeeper (Bk).

  • Fig. 5.
    Fig. 5.

    Lipidomic profiling of kidney. (A) The heat map represents log(2) values of the data normalized with the mean of the WT genotype. Lipids with ANOVA P-values<0.05 are shown. 4-week-old male WT, PPARγ2 KO, ob/ob and POKO mice (n=7–8). (B) Differentially regulated lipids between POKO and ob/ob genotypes. P-values *P<0.05, **P<0.005. DG, diacylglycerol; Cer, ceramides; PC, phosphatidylcholine; PE, phosphatidylethanolamine.

  • Fig. 6.
    Fig. 6.

    Inflammation markers and renal injury in the four genotypes. (A) Immunostaining for MCP-1, TGFβ, PTHrP and type IV collagen in the kidney from male WT, PPARγ2 KO, ob/ob and POKO mice at 4 weeks (n=4–5). Original magnification: 400×; scale bars: 50 μm. (B) Representative immunoblot for cytosolic (CE) and nuclear (NE) p65 NFκB protein in renal extracts from WT, PPARγ2 KO, ob/ob and POKO 4-week-old male mice. Levels were normalized to β-actin in the cytosolic fraction and lamin-β receptor in the nuclear fraction. Each value is the relative optical intensity of each band normalized as a percentage of that of the WT group. Values are represented in graphic (n=5–7). Data are means±s.e.m. **P<0.01 POKO vs ob/ob; ##P<0.01 POKO vs WT; ΨP<0.05 POKO vs PPARγ2 KO.

  • Fig. 7.
    Fig. 7.

    Fibrotic markers in the progression of the renal disease in the POKO mice. Representative photomicrographs for PAS staining and Masson’s trichrome staining of kidney sections from male WT, PPARγ2 KO, ob/ob and POKO mice at 4 (A) and 12 (B) weeks. Glomerular fibrosis is shown (arrows) at different ages. Original magnification: 400×. n=4–5.

Back to top

RSSRSS

 Download PDF

Email
Research Article
Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model
Cristina Martínez-García, Adriana Izquierdo, Vidya Velagapudi, Yurena Vivas, Ismael Velasco, Mark Campbell, Keith Burling, Fernando Cava, Manuel Ros, Matej Orešič, Antonio Vidal-Puig, Gema Medina-Gomez
Disease Models & Mechanisms 2012 5: 636-648; doi: 10.1242/dmm.009266
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Alerts

Article navigation

Other journals from The Company of Biologists

Advertisement

DMM and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.

Professor Elizabeth Patton appointed as DMM’s next Editor-in-Chief

We are pleased to announce that The Company of Biologists directors have appointed Professor Elizabeth Patton as DMM's new Editor-in-Chief. As Paresh Vyas writes in his Editorial, Liz ‘brings vitality and a passion for the remit of DMM, and is deeply embedded in the community.’

Did you know DMM Conference Travel Grants can be used for online meetings?

With travel restrictions still in place, we want to continue supporting early-career researchers in their careers. DMM’s Conference Travel Grants can now be used to attend virtual and online scientific meetings, workshops, conferences and training courses.

The current application round closes on 8 February 2021 – find out more.

Identification of MYOM2 as a candidate gene in hypertrophic cardiomyopathy and Tetralogy of Fallot, and its functional evaluation in the Drosophila heart

Research from Silke Sperling and colleagues uses Drosophila to identify MYOM2 as a candidate gene in congenital heart malformations in this issue’s Editor’s choice.

C. elegans as a disease model

A new Research article from Doyle et al., models spinal muscular atrophy in C. elegans to show that that targeting therapies to muscle cells is more effective than neuronal delivery. Find more research using C. elegans as a disease model in our latest subject collection.

Call for papers – The RAS Pathway: Diseases, Therapeutics and Beyond

Our upcoming special issue is now welcoming submissions until 1 April 2021. Guest-edited by Donita Brady (Perelman School of Medicine at the University of Pennsylvania, USA) and Arvin Dar (Icahn School of Medicine at Mount Sinai, USA), the issue will focus on the targeting the RAS pathway. Find out more about the issue and how to submit your manuscript.

Interview – Kim Landry-Truchon and Nicolas Houde

In an interview, first authors Kim Landry-Truchon and Nicolas Houde discuss their mouse model of the early stages of pleuropulmonary blastoma, reflecting on the implications of their work and the future of their field.